(S)-2-Aminobutyramide Hydrochloride CAS 7682-20-4 ILevetiracetam ePhakathi ePhakamileyo ecocekileyo
Ubonelelo lwabavelisi ngoBusulungekileyo obuPhezulu kunye noMgangatho oZinzileyo
(S)-2-Aminobutyramide Hydrochloride CAS 7682-20-4, Umbindi weLevetiracetam
(R)-2-Aminobutanamide Hydrochloride CAS 103765-03-3
Levetiracetam CAS 102767-28-2
Igama leMchiza | (S) -2-Aminobutyramide Hydrochloride |
Izithethantonye | H-Abu-NH2·HCl;L-2-Aminobutanamide Hydrochloride;ILevetiracetam ePhakathi |
Inombolo yeCAS | 7682-20-4 |
Inombolo yeCAT | RF-CC172 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C4H11ClN2O |
Ubunzima beMolekyuli | 138.6 |
Indawo yokunyibilika | 263℃ (ngoDisemba) |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Mhlophe ukuya kwi-Off-White Powder |
Ukuchongwa nge-IR | I-IR yokufunxa i-spectrum yesampuli njenge-Potassium Bromide dispersion ihambelana ne-spectrum erekhodiweyo efanayo ye-L-2-Amino Butyramide.HCL (5009/I) umgangatho wokusebenza . |
Ukunyibilika | Inyibilika emanzini, iNyibilika kancinane kwiMethanol |
Ukujikeleziswa okuthe ngqo | +23.0°~+27.0° (Kwisiseko esomileyo) |
Ilahleko ekomisweni | ≤0.50% |
Intsalela kwi-Ignition | ≤0.30% |
Umxholo weHydrochloride | 23.0%~28.0% |
Izinto ezinxulumeneyo | nguHPLC |
L-(+)-2-Aminobutyric Acid | ≤0.50% |
Max.Ukungacoceki komntu | ≤0.50% |
Ukungcola ngokupheleleyo | ≤1.0% |
I-Chiral Purity yi-HPLC | Isiqulatho se-R-Isomer ≤0.50% |
Isivavanyi | 98.0% ~ 102.0% (HPLC, Kwisiseko Esomileyo) |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | IiCompounds zeChiral;Umbindi weLevetiracetam (CAS: 102767-28-2) |
Indlela Yokwenziwa
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we (S) -2-Aminobutyramide Hydrochloride (CAS: 7682-20-4) enomgangatho ophezulu, uphakathi ngokuqhelekileyo kwi-synthesis yeLevetiracetam (CAS: 102767) -28-2).I-Levetiracetam yaqala ukuziswa e-US njengonyango oluncedisayo kunyango lwe-partial-seizures kubantu abadala abane-epilepsy, isilwanyana sesithathu se-antiepileptic.
I-Shanghai Ruifu Chemical Co., Ltd. idlala indima ebalulekileyo kwi-chemistry ye-chiral, inkampani izinikele ekuveliseni i-chiral compounds.Iimveliso zethu zinconywa ngokubanzi ngabathengi.